The Bioanalysis Laboratory works in partnership with multidisciplinary teams of scientists from across Argonne National Laboratory to address national security concerns. The Bioanalysis Laboratory develops laboratory-based and computationally-based platforms for the detection and characterization of biological agents (i.e. B. anthracis &  SARS-CoV-2 virus) from complex environmental backgrounds. The Lab also develops bionuclear approaches (biologically-based and/or -enabled technologies) to support U.S. Nuclear Counterproliferation goals.

Bioanalysis Laboratory Highlights:

• Laboratory-based biodetection projects include tracing anthrax outbreaks in Jordan and Pakistan.
• Computationally-based biodetection projects include AI-enabled identification of genetic engineering in the environment.
• Bionuclear approaches include the use of soil microbial communities to detect nuclear proliferation.
• The Lab leverages unique expertise and resources from across the Laboratory including next generation sequencing, genomic/metagenomic analysis, high performance computing, artificial intelligence/machine learning, geographic information systems and nuclear fuel cycle experts.
• The facility includes preparation laboratories, Biological Safety Level 2 (BSL-2) laboratories and a Class 1000 cleanroom.